S.Biomedics Co., Ltd. (KOSDAQ:304360)

S.Biomedics Statistics

Total Valuation

S.Biomedics has a market cap or net worth of KRW 273.96 billion. The enterprise value is 280.03 billion.

Market Cap	273.96B
Enterprise Value	280.03B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

S.Biomedics has 11.86 million shares outstanding. The number of shares has increased by 3.70% in one year.

Current Share Class	11.86M
Shares Outstanding	11.86M
Shares Change (YoY)	+3.70%
Shares Change (QoQ)	+0.82%
Owned by Insiders (%)	22.60%
Owned by Institutions (%)	0.01%
Float	8.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.02
PB Ratio	18.37
P/TBV Ratio	38.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.68
EV / Sales	16.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-40.15

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 1.28.

Current Ratio	2.17
Quick Ratio	1.91
Debt / Equity	1.28
Debt / EBITDA	n/a
Debt / FCF	-2.74
Interest Coverage	-7.77

Financial Efficiency

Return on equity (ROE) is -65.37% and return on invested capital (ROIC) is -14.52%.

Return on Equity (ROE)	-65.37%
Return on Assets (ROA)	-10.83%
Return on Invested Capital (ROIC)	-14.52%
Return on Capital Employed (ROCE)	-20.31%
Revenue Per Employee	316.60M
Profits Per Employee	-163.67M
Employee Count	54
Asset Turnover	0.48
Inventory Turnover	3.66

Taxes

In the past 12 months, S.Biomedics has paid 104.25 million in taxes.

Income Tax	104.25M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.19% in the last 52 weeks. The beta is 1.83, so S.Biomedics's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	-14.19%
50-Day Moving Average	22,652.60
200-Day Moving Average	22,067.25
Relative Strength Index (RSI)	45.21
Average Volume (20 Days)	176,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S.Biomedics had revenue of KRW 17.10 billion and -8.84 billion in losses. Loss per share was -754.38.

Revenue	17.10B
Gross Profit	7.77B
Operating Income	-6.18B
Pretax Income	-7.40B
Net Income	-8.84B
EBITDA	-4.32B
EBIT	-6.18B
Loss Per Share	-754.38

Balance Sheet

The company has 20.42 billion in cash and 19.13 billion in debt, giving a net cash position of 1.28 billion or 108.34 per share.

Cash & Cash Equivalents	20.42B
Total Debt	19.13B
Net Cash	1.28B
Net Cash Per Share	108.34
Equity (Book Value)	14.91B
Book Value Per Share	637.43
Working Capital	13.77B

Cash Flow

In the last 12 months, operating cash flow was -3.99 billion and capital expenditures -2.98 billion, giving a free cash flow of -6.97 billion.

Operating Cash Flow	-3.99B
Capital Expenditures	-2.98B
Free Cash Flow	-6.97B
FCF Per Share	-588.03

Margins

Gross margin is 45.44%, with operating and profit margins of -36.12% and -51.70%.

Gross Margin	45.44%
Operating Margin	-36.12%
Pretax Margin	-43.29%
Profit Margin	-51.70%
EBITDA Margin	-25.29%
EBIT Margin	-36.12%
FCF Margin	n/a

Dividends & Yields

S.Biomedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.70%
Shareholder Yield	-3.70%
Earnings Yield	-3.23%
FCF Yield	-2.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S.Biomedics has an Altman Z-Score of 4.3 and a Piotroski F-Score of 3.

Altman Z-Score	4.3
Piotroski F-Score	3